Specificity of Lower Urinary Tract Symptoms in Neuromyelitis Optica in Comparison With Multiple Sclerosis Patients
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: The aim of this study was to describe lower urinary tract symptoms in neuromyelitis optica (NMO), and to compare these data with urinary disorders observed in multiple sclerosis (MS) patients. Methods: Retrospective study of data collected from January 1997 to July 2017 using the database from a Neuro-Urology Department of a university hospital. NMO and MS patients were matched for sex, age, and Expanded Disability Status Scale (EDSS) Results: Twenty-six patients with NMO were included and compared with 33 MS patients. Mean age was 41.6 years (standard deviation [SD], 14,8), mostly female patients (24 vs. 2 males). Mean EDSS was 4.6 (SD, 1.8) in the 2 groups. In NMO group, 57% of the patients (n=15) had overactive bladder with urgency and urge incontinence and 38.5% (n=10) of them had nocturia. Voiding symptoms was observed in 69.2% of the patients (n=18); 42.3% of NMO patients performed self-intermittent catheterization versus 12.1% in MS patients (P=0.012). Low bladder compliance and severe urinary tract infections (pyelonephritis) were more frequent in NMO than in MS patients (respectively 15% vs. 0%, P=0.016 and 42% vs. 12%, P=0.024). Conclusions: Lower urinary tract symptoms, especially overactive bladder and urinary retention, are frequent in NMO. Low bladder compliance, serious urinary infections, and high prevalence of urinary retention requiring self-intermittent catheterization are the main symptoms significantly more frequent than in MS.
Abstract
Purpose: The aim of this study was to describe lower urinary tract symptoms in neuromyelitis optica (NMO), and to compare these data with urinary disorders observed in multiple sclerosis (MS) patients. Methods: Retrospective study of data collected from January 1997 to July 2017 using the database from a Neuro-Urology Department of a university hospital. NMO and MS patients were matched for sex, age, and Expanded Disability Status Scale (EDSS) Results: Twenty-six patients with NMO were included and compared with 33 MS patients. Mean age was 41.6 years (standard deviation [SD], 14,8), mostly female patients (24 vs. 2 males). Mean EDSS was 4.6 (SD, 1.8) in the 2 groups. In NMO group, 57% of the patients (n=15) had overactive bladder with urgency and urge incontinence and 38.5% (n=10) of them had nocturia. Voiding symptoms was observed in 69.2% of the patients (n=18); 42.3% of NMO patients performed self-intermittent catheterization versus 12.1% in MS patients (P=0.012). Low bladder compliance and severe urinary tract infections (pyelonephritis) were more frequent in NMO than in MS patients (respectively 15% vs. 0%, P=0.016 and 42% vs. 12%, P=0.024). Conclusions: Lower urinary tract symptoms, especially overactive bladder and urinary retention, are frequent in NMO. Low bladder compliance, serious urinary infections, and high prevalence of urinary retention requiring self-intermittent catheterization are the main symptoms significantly more frequent than in MS.
참고문헌 (24)
- Allbutt TC, "On the ophthalmoscopic signs of spinal disease", Lancet, 95, pp.76~78 (1870)[DOI]
- Wingerchuk DM, "The clinical course of neuromyelitis optica (Devic's syndrome)", Neurology, 53, pp.1107~1114 (1999)[DOI]
- Lennon VA, "A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis", Lancet, 364, pp.2106~2112 (2004)[DOI]
- Wingerchuk DM, "International consensus diagnostic criteria for neuromyelitis optica spectrum disorders", Neurology, 85, pp.177~189 (2015)[DOI]
- Bart S, "Lower urinary tract dysfunction and multiple sclerosis", Prog Urol, 17, pp.358~364 (2007)[DOI]
- Amarenco G, "Clinical and urodynamic evaluations of urinary disorders in multiple sclerosis", Ann Phys Rehabil Med, 57, pp.277~287 (2014)[DOI]
- de Carvalho FL, "Voiding dysfunction in patients with neuromyelitis optica spectrum disorders", Neurourol Urodyn, 35, pp.39~43 (2016)[DOI]
- Mutch K, "Bladder and bowel dysfunction affect quality of life. A cross sectional study of 60 patients with aquaporin-4 antibody positive Neuromyelitis Optica spectrum disorder", Mult Scler Relat Disord, 4, pp.614~618 (2015)[DOI]
- McKinley WO, "Long-term medical complications after traumatic spinal cord injury: a regional model systems analysis", Arch Phys Med Rehabil, 80, pp.1402~1410 (1999)[DOI]
- DeVivo MJ, "Recent trends in mortality and causes of death among persons with spinal cord injury", Arch Phys Med Rehabil, 80, pp.1411~1419 (1999)[DOI]
- Ruffion A, "Groupe d'Etudes de Neuro-Urologie de Langue Francaise (GENULF) guidelines for the management of spinal cord injury and spina bifida patients", Prog Urol, 17, pp.631~633 (2007)[DOI]
- Drori T, "Diagnosis and classification of neuromyelitis optica (Devic's syndrome)", Autoimmun Rev, 13, pp.531~533 (2014)[DOI]
- de Seze M, "The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines", Mult Scler, 13, pp.915~928 (2007)[DOI]
- Papais-Alvarenga RM, "Clinical course of optic neuritis in patients with relapsing neuromyelitis optica", Arch Ophthalmol, 126, pp.12~16 (2008)[DOI]
- Ghezzi A, "Clinical characteristics, course and prognosis of relapsing Devic's Neuromyelitis Optica", J Neurol, 251, pp.47~52 (2004)[DOI]
- Nortvedt MW, "Reduced quality of life among multiple sclerosis patients with sexual disturbance and bladder dysfunction", Mult Scler, 7, pp.231~235 (2001)[DOI]
- Vitkova M, "Health-related quality of life in multiple sclerosis patients with bladder, bowel and sexual dysfunction", Disabil Rehabil, 36, pp.987~992 (2014)[DOI]
- McDonald WI, "Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis", Ann Neurol, 50, pp.121~127 (2001)[DOI]
- Kurtzke JF, "Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)", Neurology, 33, pp.1444~1452 (1983)[DOI]
- Schafer W, "Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies", Neurourol Urodyn, 21, pp.261~274 (2002)[DOI]
- Gajewski JB, "An International Continence Society (ICS) report on the terminology for adult neurogenic lower urinary tract dysfunction (ANLUTD)", Neurourol Urodyn, 37, pp.1152~1161 (2018)[DOI]
- Trebst C, "Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS)", J Neurol, 261, pp.1~16 (2014)
- Mealy MA, "Epidemiology of neuromyelitis optica in the United States: a multicenter analysis", Arch Neurol, 69, pp.1176~1180 (2012)
- Jacob A, "The epidemiology of neuromyelitis optica amongst adults in the Merseyside county of United Kingdom", J Neurol, 260, pp.2134~2137 (2013)[DOI]